We would love to hear your thoughts about our site and services, please take our survey here.
Just watched the proactive thing.. yes marku did seem agitated.
May be cause this was ghis 4th appointment and being up since 2 am
It was funny how he went off script about Finland able to defeat a Russian attack.
The markets seem to if annoyed him, and rightly so. We all know that putins personal war is doing everyone in!
Jonathan-knowles, "if you think PD1 was big, bex it's going to be bigger!"
Dobt forget that
https://www.faron.com/media/videos
I think this is the finish version of the recent presentation in Finnish.
Wo during if any of our Finnish friends here have watched it and if there are anything else marku says that's different from the English version?
https://www.labiotech.eu/trends-news/biopharma-company-faron-announces-escalation-data-cancer-treatment-study/
I think one lesson learned from traumakine is phase 3 trials need more data. They fell at this last hurdle cause o es receiving tramakine where also on steroids which nullified the treatment.
Finding out who bex will work on and who not I key to getting 100% success rate in phase 3 trials and that's what they have done.
It's looking good guys
"Just to be clear!"
They answered one of my questions, bexcombo, who what drug and when
Didn't catch the full answer :)
Merck – the manufacturer of Keytruda (pembrolizumab)
Confirmed that's who they will be partying with for bexcombo.. or at least its Merck drug they will combo with.
Could they be a possible financial partner?
Mercy as a poss
Who did they say they had a very good relationship with in the US... Anderson something?
Jonathan Knowles is very confident that bex works.
Also he is impressed at the amount of information they have at this stage of trials
We can ask questions!
Google is now showing £2
Imagine being one of those end of line patients, exhusted all other options, probably chemo and radiated to half death, and then comes bex and 14.9 months later, you are still alive!
"Median overall survival based on patients from Part I and II (n=138) was 14.9 months for patients who benefited from treatment with bexmarilimab compared to 4.4 months for those who did not, representing a 3.4-fold increase"
4 trades value at £9,994
That looks like 10 grand less 6 quid commission
https://www.faron.com/faron/meet-team
Q&A with Dr. Jonathan Knowles, Scientific Advisory Board Chair
May 2022
Google showing 1.94
Things are looking up.
Said it before as the saying goes, 'the darkest hour is just before dawn"
Brig on the sunshine Markku
Google showing 1.80!
Perhaps the ship has finally turned
Looking forward to this, hopefully new data that will raise the Share price
"We've significantly advanced our bexmarilimab development program in 2022 and on this webcast, will provide updates on current trials and important milestones we expect to achieve over the coming months."
We are not on anybodies radar ATM.
Maybe after this conference thing the faron name may become known.
"Traumakine holds the promise to be an important 'golden hour' therapeutic within combat scenarios where there remains a serious unmet need."